BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18195234)

  • 1. Bilateral retinal vasculopathy in a patient with dyskeratosis congenita.
    Teixeira LF; Shields CL; Marr B; Horgan N; Shields JA
    Arch Ophthalmol; 2008 Jan; 126(1):134-5. PubMed ID: 18195234
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis.
    Alldredge CD; Garretson BR
    Retina; 2003 Feb; 23(1):113-6. PubMed ID: 12652245
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravitreal triamcinolone acetonide for bilateral acquired parafoveal telangiectasis.
    Martinez JA
    Arch Ophthalmol; 2003 Nov; 121(11):1658-9. PubMed ID: 14609935
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
    Er H
    Am J Ophthalmol; 2006 Oct; 142(4):710; author reply 710. PubMed ID: 17011888
    [No Abstract]   [Full Text] [Related]  

  • 5. Retinal vasculopathy in a family with autosomal dominant dyskeratosis congenita.
    Johnson CA; Hatfield M; Pulido JS
    Ophthalmic Genet; 2009 Dec; 30(4):181-4. PubMed ID: 19852575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of intravitreal triamcinolone acetonide injection in unilateral idiopathic juxtafoveal telangiectasis.
    Li KK; Goh TY; Parsons H; Chan WM; Lam DS
    Clin Exp Ophthalmol; 2005 Oct; 33(5):542-4. PubMed ID: 16181291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correspondence.
    Lorenzo-Carrero J
    Retina; 2009 Jun; 29(6):868-9; author reply 869. PubMed ID: 19516126
    [No Abstract]   [Full Text] [Related]  

  • 8. Juxtafoveal telangiectasias.
    Querques G; Delle Noci N
    Ophthalmology; 2008 Sep; 115(9):1636; author reply 1636. PubMed ID: 18762079
    [No Abstract]   [Full Text] [Related]  

  • 9. Macular infarction after inadvertent intracameral cefuroxime.
    Qureshi F; Clark D
    J Cataract Refract Surg; 2011 Jun; 37(6):1168-9. PubMed ID: 21596262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreous ranibizumab as treatment for macular telangiectasia type 2.
    Lira RP; Silva VB; Cavalcanti TM; de Souza AC; Pinto AP
    Arch Ophthalmol; 2010 Aug; 128(8):1075-8. PubMed ID: 20697014
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravitreal triamcinolone injection in the treatment of idiopathic juxtafoveal telangiectasis].
    Maia OO; Takahashi WY; Bonanomi MT; Nascimento VP; Melo CS
    Arq Bras Oftalmol; 2006; 69(6):941-4. PubMed ID: 17273694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
    Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
    Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
    Williamson TH; O'Donnell A
    Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion.
    Jonas JB; Kreissig I; Degenring RF
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):782-3. PubMed ID: 12271378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
    Chen SD; Sundaram V; Lochhead J; Patel CK
    Am J Ophthalmol; 2006 May; 141(5):876-883. PubMed ID: 16527226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior retinal vasculitis associated with multiple sclerosis.
    Mackenzie PJ; Chang TS; Hay D
    Retina; 2002 Feb; 22(1):133-4. PubMed ID: 11884901
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasia.
    Wu L; Evans T; Arévalo JF; Berrocal MH; Rodríguez FJ; Hsu M; Sánchez JG
    Retina; 2008 Feb; 28(2):314-9. PubMed ID: 18301037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral Proliferative Retinopathy Associated With Hoyeraal-Hreidarsson Syndrome, a Severe Form of Dyskeratosis Congenita.
    Allingham MJ
    Ophthalmic Surg Lasers Imaging Retina; 2016 Apr; 47(4):366-8. PubMed ID: 27065378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral retinal vasculopathy associated with autosomal dominant dyskeratosis congenita.
    Vaz-Pereira S; Pacheco PA; Gandhi S; Kulasekararaj AG; Marsh JC; Pal B; Mufti GJ
    Eur J Ophthalmol; 2013; 23(5):772-5. PubMed ID: 23661544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.